Abstract
In almost half of allogeneic hematopoietic progenitor cell (HPC) transplants, a related donor (RD) is used, yet a lack of standardized guidelines means that their care is heterogeneous. Changes to regulatory standards aim to improve uniformity, but adherence to these regulations can prove logistically difficult for the transplant centers (TCs) managing RDs. Discussion has ensued around possible alternative models of related donor care and a session at the European Society for Blood and Marrow Transplantation (EBMT) annual meeting in 2013 debated the question of whether a role exists for unrelated donor registries in the management of ‘related’ donors. In this overview, we discuss the issues raised at this debate and the pros and cons of donor registry involvement in various aspects of RD management. By examining existing models of related donor care that have been adopted by members of the World Marrow Donor Association (WMDA), we look for ways to enhance and homogenize RD care, while also enabling transplant centers to meet standards required for mandatory accreditation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
WMDA. International Standards for Unrelated Hematopoietic Progenitor Cell Donor Registries standards W. International Standards for Unrelated Hematopoietic Progenitor Cell Donor Registries. Available at http://www.worldmarrow.org/fileadmin/Committees/STDC/20140101-STDC-WMDA_Standards.pdf. Accessed 9 October 2013.
Clare S, Mank A, Stone R, Davies M, Potting C, Apperley JF et al. Management of related donor care: a European survey. Bone Marrow Transplant 2010; 45: 97–101.
O'Donnell PV, Pedersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D et al. Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States. Blood 2010; 115: 5097–5101.
van Walraven SM, Nicoloso-de Faveri G, Axdorph-Nygell UA, Douglas KW, Jones DA, Lee SJ et al. Family donor care management: principles and recommendations. Bone Marrow Transplant 2010; 45: 1269–1273.
Coluccia P, Crovetti G, Del Fante C, Dallavalle FM, Laszlo D, Ferremi P et al. Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres. Blood Transfus 2012; 10: 440–447.
Joint Accreditation Committee-ISCT & EBMT. International standards for cellular therapy product collection processing and adminstration. 5th edition. Available at http://www.jacie.org. Accessed 9 October 2013.
Halter JP, van Walraven SM, Worel N, Bengtsson M, Hagglund H, Nicoloso de Faveri G et al. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant 2013; 48: 220–225.
Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009; 94: 94–101.
Horowitz MM, Confer DL . Evaluation of hematopoietic stem cell donors. Hematology / the Education Program of the American Society of Hematology. Am Soc Hematol Educ Program 2005; 1: 469–475.
Wiersum-Osselton JC, van Walraven SM, Bank I, Lenselink AM, Fibbe WE, van der Bom JG et al. Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single-center cohort study. Transfusion 2013; 53: 96–103.
Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S et al. PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant 2013; 49: 195–200.
Switzer GE, Dew MA, Magistro CA, Goycoolea JM, Twillman RK, Alter C et al. The effects of bereavement on adult sibling bone marrow donors' psychological well-being and reactions to donation. Bone Marrow Transplant 1998; 21: 181–188.
Foster RS . Conflicts of interest: recognition, disclosure, and management. J Am Coll Surg 2003; 196: 505–517.
WHO guiding principles on human cell, tissue and organ transplantation. Available at http://www.who.int/transplantation/Guiding_PrinciplesTransplantation_WHA63.22en.pdf. Accessed 9 October 2013.
Sacchi N, Costeas P, Hartwell L, Hurley CK, Raffoux C, Rosenmayr A et al. Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Bone Marrow Transplant 2008; 42: 9–14.
van Walraven SM, Straathof LM, Switzer GE, Lankester A, Korthof ET, Brand A et al. Immediate and long-term somatic effects, and health-related quality of life of BM donation during early childhood. A single-center report in 210 pediatric donors. Bone Marrow Transplant 2013; 48: 40–45.
Pulsipher MA, Nagler A, Iannone R, Nelson RM . Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 2006; 46: 422–433.
Pulsipher MA . A donor's a person, no matter how small. Blood 2012; 119: 2705–2706.
Styczynski J, Balduzzi A, Gil L, Labopin M, Hamladji RM, Marktel S et al. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study. Blood 2012; 119: 2935–2942.
Simmons RG, Schimmel M, Butterworth VA . The self-image of unrelated bone marrow donors. J Health Soc Behav 1993; 34: 285–301.
van Walraven SM, Ball LM, Koopman HM, Switzer GE, Ropes-de Jong CM, de Jong A et al. Managing a dual role-experiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children. Psychooncology 2012; 21: 168–175.
Taghavi R, Mahdavi R, Toufani H . The psychological effects of kidney donation on living kidney donors (related and unrelated). Transplant Proc 2001; 33: 2636–2637.
Ethics Committee of the Transplantation S. The consensus statement of the Amsterdam Forum on the Care of the Live Kidney Donor. Transplantation 2004; 78: 491–492.
WHO. Notify Report: Exploring vigilance notification for organs tissues and cells 2011. Available at http://www.notifylibrary.org/sites/default/files/BOOK%20NOTIFY.pdf.
Shaw BE, Confer DL, Hwang WY, Pamphilon DH, Pulsipher MA . Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. Haematologica 2011; 96: 942–947.
Pentz RD, Alderfer MA, Pelletier W, Stegenga K, Haight AE, Hendershot KA et al. Unmet needs of siblings of pediatric stem cell transplant recipients. Pediatrics 2014; 133: e1156–e1162.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Anthias, C., van Walraven, S., Sørensen, B. et al. Related hematopoietic cell donor care: is there a role for unrelated donor registries?. Bone Marrow Transplant 50, 637–641 (2015). https://doi.org/10.1038/bmt.2015.15
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.15
This article is cited by
-
Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group
Bone Marrow Transplantation (2020)
-
Variations in practice in UK transplant centers: results of a related donor care survey
Bone Marrow Transplantation (2016)